Find key information for shareholders in 4D pharma plc

Registered office

4D pharma plc
Third Floor
9 Bond Court
Leeds LS1 2JZ

Share information

There are 64,858,150 ordinary shares in issue. There are no ordinary shares held in treasury. Therefore, the total number of voting rights in the Company is 64,858,150.

Please view the table below for the interests of shareholders of 3% or more which have been notified to the Company. Other directors who are also shareholders include Thomas Engelen (0.8%).

Insofar as the Company is aware, the percentage of the Company’s issued ordinary shares that is not in public hands is 72.1%.

There are no restrictions as to the transfer of ordinary shares.

Major shareholders

Ordinary shares held%
Woodford Investment Management LLP17,514,56127.0%
Invesco Asset Management Limited9,163,61714.1%
David Robert Norwood7,000,00010.8%
Duncan Joseph Peyton6,250,286
9.6%
Alexander James Stevenson6,250,2869.6%
Lansdowne Partners
3,000,0004.6%

This information was last updated on 10 March 2017.

Meetings and voting

Advisers and registrars

Zeus Capital Limited
82 King Street
Manchester M2 4WQ

and

41 Conduit Street
London W1S 2YQ

Investec Bank plc

2 Gresham Street

London

EC2V 7QP

RSM UK Audit LLP
3 Hardman Street
Manchester M3 3HF

Capita Asset Services
The Registry
34 Beckenham Road
Beckenham
Kent BR3 4TU

BACK TO TOP